These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 1127088)
1. The effect of acute hypercalcemia on growth hormone release in man. Ajlouni K; Hagen TC J Clin Endocrinol Metab; 1975 May; 40(5):780-2. PubMed ID: 1127088 [TBL] [Abstract][Full Text] [Related]
2. Effects of hypercalcemia on serum concentrations of magnesium, potassium, and phosphate and urinary excretion of electrolytes in horses. Toribio RE; Kohn CW; Rourke KM; Levine AL; Rosol TJ Am J Vet Res; 2007 May; 68(5):543-54. PubMed ID: 17472456 [TBL] [Abstract][Full Text] [Related]
3. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus. Huhn WC; Hartman ML; Pezzoli SS; Thorner MO J Clin Endocrinol Metab; 1993 May; 76(5):1202-8. PubMed ID: 8496311 [TBL] [Abstract][Full Text] [Related]
4. Infusions of parathyroid hormone in ruminants: hypercalcemia and reduced plasma 1,25-dihydroxyvitamin D concentrations. Hove K; Horst RL; Littledike ET; Beitz DC Endocrinology; 1984 Mar; 114(3):897-903. PubMed ID: 6546544 [TBL] [Abstract][Full Text] [Related]
5. Influence of acute experimental hypercalcemia on peripheral insulin sensitivity in healthy subjects. Prager R; Schernthaner G; Graf H; Chichini G; Luger A Diabetes Res; 1986 May; 3(4):199-201. PubMed ID: 3527517 [TBL] [Abstract][Full Text] [Related]
6. Short term continuous intravenous infusion of growth hormone (GH) inhibits GH-releasing hormone-induced GH secretion: a time-dependent effect. Rosenthal SM; Kaplan SL; Grumbach MM J Clin Endocrinol Metab; 1989 Jun; 68(6):1101-5. PubMed ID: 2498383 [TBL] [Abstract][Full Text] [Related]
8. Divergent influences of calcium ions on releasing factor-stimulated anterior pituitary hormone secretion in normal man. Veldhuis JD; Borges JL; Drake CR; Rogol AD J Clin Endocrinol Metab; 1984 Jul; 59(1):56-61. PubMed ID: 6427272 [TBL] [Abstract][Full Text] [Related]
9. The effect of acute hypercalcemia on prolactin release in man. Ajlouni K; El Khateeb M Horm Metab Res; 1981 May; 13(5):282-4. PubMed ID: 7262825 [TBL] [Abstract][Full Text] [Related]
10. Divergent influences of the structurally dissimilar calcium entry blockers, diltiazem and verapamil, on thyrotropin- and gonadotropin-releasing hormone-stimulated anterior pituitary hormone secretion in man. Veldhuis JD; Borges JL; Drake CR; Rogol AD; Kaiser DL; Thorner MO J Clin Endocrinol Metab; 1985 Jan; 60(1):144-9. PubMed ID: 3880562 [TBL] [Abstract][Full Text] [Related]
11. Rapidity of plasma 1,25-dihydroxyvitamin D responses to hypo- and hypercalcemia in steers. Blum JW; Trechsel U; Born W; Tobler PH; Taylor CM; Binswanger U; Fischer JA Endocrinology; 1983 Aug; 113(2):523-6. PubMed ID: 6409584 [TBL] [Abstract][Full Text] [Related]
12. Effect of acute hypercalcemia on thyrotropin (TSH) and triiodothyronine responses to TSH-releasing hormone in man. Gillet C; Corvilain J; Matte-Hiriart J; Willems D; Bergmann P J Clin Endocrinol Metab; 1990 Aug; 71(2):516-9. PubMed ID: 2116441 [TBL] [Abstract][Full Text] [Related]
13. Effects of disodium EDTA and calcium infusion on prolactin and thyrotropin responses to thyrotropin-releasing hormone in healthy man. Dudczak R; Waldhäusl WK; Bratusch-Marrain P J Clin Endocrinol Metab; 1983 Mar; 56(3):603-7. PubMed ID: 6401762 [TBL] [Abstract][Full Text] [Related]
14. Dual effects of growth hormone (GH)-releasing hormone infusion in normal men: somatotroph desensitization and increase in releasable GH. Vance ML; Kaiser DL; Rivier J; Vale W; Thorner MO J Clin Endocrinol Metab; 1986 Mar; 62(3):591-4. PubMed ID: 3080467 [TBL] [Abstract][Full Text] [Related]
15. Evidence for a limited growth hormone (GH)-releasing hormone (GHRH)-releasable quantity of GH: effects of 6-hour infusions of GHRH on GH secretion in normal man. Vance ML; Kaiser DL; Evans WS; Thorner MO; Furlanetto R; Rivier J; Vale W; Perisutti G; Frohman LA J Clin Endocrinol Metab; 1985 Feb; 60(2):370-5. PubMed ID: 3917460 [TBL] [Abstract][Full Text] [Related]
16. Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man. Giustina A; Girelli A; Doga M; Bodini C; Bossoni S; Romanelli G; Wehrenberg WB J Clin Endocrinol Metab; 1990 Sep; 71(3):580-4. PubMed ID: 2118535 [TBL] [Abstract][Full Text] [Related]
17. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans. SaccĂ L; Sherwin R; Hendler R; Felig P J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832 [TBL] [Abstract][Full Text] [Related]
18. Effect of acute hypercalcemia on human esophageal motility. Danielides IC; Mellow MH Gastroenterology; 1978 Dec; 75(6):1115-9. PubMed ID: 710863 [TBL] [Abstract][Full Text] [Related]
19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of pulsatile growth hormone secretion by continuous infusion of a growth hormone-releasing peptide mimetic, L-692,429, in older adults--a clinical research center study. Chapman IM; Hartman ML; Pezzoli SS; Thorner MO J Clin Endocrinol Metab; 1996 Aug; 81(8):2874-80. PubMed ID: 8768844 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]